These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6477955)

  • 1. A simple and rapid anti-ligand enzyme immunoassay for visualization of low-density lipoprotein membrane receptors.
    Dresel HA; Otto I; Weigel H; Schettler G; Via DP
    Biochim Biophys Acta; 1984 Oct; 795(3):452-7. PubMed ID: 6477955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visualization of lipoprotein receptors by ligand blotting.
    Daniel TO; Schneider WJ; Goldstein JL; Brown MS
    J Biol Chem; 1983 Apr; 258(7):4606-11. PubMed ID: 6300091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The low density lipoprotein receptor on human peripheral blood monocytes and lymphocytes: visualization by ligand blotting and immunoblotting techniques.
    Semenkovich CF; Ostlund RE
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1279-87. PubMed ID: 3700586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the low-density-lipoprotein receptor with biotin-low-density lipoprotein. A rapid new method for ligand blotting.
    Wade DP; Knight BL; Soutar AK
    Biochem J; 1985 Aug; 229(3):785-90. PubMed ID: 4052026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoassay of bovine and human low-density-lipoprotein receptors using monoclonal antibodies.
    Knight BL; Preyer S; Soutar AK
    Biochem J; 1986 Sep; 238(2):405-10. PubMed ID: 3800945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of cholesterol-rich remnant lipoproteins by human monocyte-derived macrophages is mediated by low density lipoprotein receptors.
    Koo C; Wernette-Hammond ME; Garcia Z; Malloy MJ; Uauy R; East C; Bilheimer DW; Mahley RW; Innerarity TL
    J Clin Invest; 1988 May; 81(5):1332-40. PubMed ID: 3163347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding characteristics of reduced hepatic receptors for acetylated low-density lipoprotein and maleylated bovine serum albumin.
    Ottnad E; Via DP; Sinn H; Friedrich E; Ziegler R; Dresel HA
    Biochem J; 1990 Feb; 265(3):689-98. PubMed ID: 2154967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of a 60K molecular weight luteinizing hormone-releasing hormone receptor in solubilized adrenal membranes by a ligand-immunoblotting technique.
    Eidne KA; Hendricks DT; Millar RP
    Endocrinology; 1985 May; 116(5):1792-5. PubMed ID: 2985361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of the low density lipoprotein receptor.
    Schneider WJ
    J Cell Biochem; 1983; 23(1-4):95-106. PubMed ID: 6327742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoenzyme assessment of human apoB-lipoprotein binding to immobilized receptor of low density lipoproteins. 2. Binding of isolated lipoproteins.
    Tsibulsky VP; Yakushkin VV; Preobrazhensky SN
    Biochemistry (Mosc); 1997 Jun; 62(6):603-8. PubMed ID: 9284540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins.
    Gianturco SH; Lin AH; Hwang SL; Young J; Brown SA; Via DP; Bradley WA
    J Clin Invest; 1988 Nov; 82(5):1633-43. PubMed ID: 3183059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilization and purification of an acetyl-LDL binding membrane protein from human leukocytes.
    Dresel HA; Schettler G; Via DP
    Agents Actions Suppl; 1984; 16():153-61. PubMed ID: 6592955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-blotting visualization of the LDL receptor in plasma membranes and in two classes of coated vesicles from adrenocortical cells.
    Weintraub H; Bomsel M; de Paillerets C; Néant I; Ayrault-Jarrier M; Alfsen A
    FEBS Lett; 1985 May; 184(2):263-7. PubMed ID: 3922787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the low-density-lipoprotein receptor from bovine adrenal cortex, rabbit and rat liver and adrenal glands by lipoprotein blotting.
    Kroon PA; Thompson GM; Chao YS
    Biochem J; 1984 Oct; 223(2):329-35. PubMed ID: 6497851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of a bovine acetyl low density lipoprotein receptor.
    Kodama T; Reddy P; Kishimoto C; Krieger M
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9238-42. PubMed ID: 3194423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoenzyme assessment of human apoB-lipoprotein binding to immobilized receptor of low density lipoproteins. 1. Preparation of anti-receptor monoclonal antibodies.
    Tsibulsky VP; Yakushkin VV; Tikhomirov OYu ; Preobrazhensky SN
    Biochemistry (Mosc); 1997 Jun; 62(6):596-602. PubMed ID: 9284539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of the low density lipoprotein (LDL) receptor on nitrocellulose paper with colloidal gold-LDL conjugates.
    Roach PD; Zollinger M; Noël SP
    J Lipid Res; 1987 Dec; 28(12):1515-21. PubMed ID: 3430073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Horizontal semi-dry electroblotting for the detection of the low density lipoprotein receptor in solubilized liver membranes.
    Himber J
    Electrophoresis; 1993 Aug; 14(8):794-7. PubMed ID: 8404824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double labeling procedure for lipoproteins: independent visualization of dual ligand-receptor interaction with colloidal gold- and 125I-labeled ligands.
    Steyrer E; Kostner GM; Schneider WJ
    Anal Biochem; 1995 Mar; 226(1):44-50. PubMed ID: 7785778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein receptors in acute myelogenous leukemia: failure to detect increased low-density lipoprotein (LDL) receptor numbers in cell membranes despite increased cellular LDL degradation.
    Rudling M; Gåfvels M; Parini P; Gahrton G; Angelin B
    Am J Pathol; 1998 Dec; 153(6):1923-35. PubMed ID: 9846982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.